Cancer Research UK logo.
SearchDonate
  • Search

A study of a new drug called OMO-1 for people with advanced solid tumours

Overview

Cancer types:

All cancer types, Secondary cancers

Status:

Closed

Phase:

Phase 1/2

Details

This study is for people who have an advanced solid tumour (particularly lung cancer).

It is for people who have 1 of the following:

  • cancer that has spread or continued to grow despite other treatments

  • cancer that is newly diagnosed, has spread and can’t be treated with standard treatment

A solid tumour is any type of cancer apart from leukaemia or lymphoma.

An advanced solid tumour is a cancer that has grown into surrounding tissues (locally advanced) or spread elsewhere in the body (advanced).

Recruitment start: 8 August 2017

Recruitment end: 9 December 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Martjin Paul Lolkema

Supported by

OCTIMET Oncology NV

Last reviewed: 02 Dec 2020

CRUK internal database number: 15514

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.